Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines (Q56981025)
Jump to navigation
Jump to search
scientific article published on 01 June 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines |
scientific article published on 01 June 2000 |
Statements
Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines (English)
Wan Y
Pilon A
Zhu Q